Henry Meds Tirzepatide Review
Released: Last reviewed: Provider data verified: Updated:
Henry Meds prices compounded tirzepatide at $349 a month, all-inclusive per its own page (read September 17, 2026), with async-only intake. Runs a 503A pharmacy model. Once among the lowest-priced compounded options, it is now the highest month-to-month figure on this site’s tirzepatide table. Trade-offs: async-only with no video consult; limited pharmacy disclosure beyond 503A.
Henry Meds at a glance
| Pricing | tirzepatide $349/mo |
|---|---|
| Pharmacy | 503A only |
| Clinician | NP/PA |
| States | 50 states |
| Editorial score | 78 / 100 |
About Henry Meds
Henry Meds is a compounded-GLP-1-focused telehealth provider offering subscription-based semaglutide and tirzepatide programs. Known for high marketing visibility in the 2023–2024 compounded GLP-1 expansion period; its tirzepatide page now prints $349 a month with first-month offers, and its GLP-1 hub “starts at $179/month” without naming the medication.
Clinical & business model
Subscription model with bundled medication. Henry Meds pioneered the flat-monthly-rate compounded GLP-1 approach that many telehealth providers later adopted. Initial prescription requires provider review and basic intake; ongoing care includes asynchronous messaging.
What Henry Meds does well
- Established compounded GLP-1 specialist with operational scale
- Subscription pricing with medication bundled
- Streamlined intake process
- Strong brand awareness in the cash-pay GLP-1 market
Trade-offs to consider
- Limited public disclosure of compounding pharmacy partners and 503A/503B designation
- Less emphasis on integrated coaching and lifestyle support compared to higher-end programs
- Less clinical oversight detail published vs MD/DO-led models
- Post-2024 regulatory environment for compounded tirzepatide creates ongoing program uncertainty
Who Henry Meds is best for
Cash-pay patients comfortable with a streamlined, lower-touch program who prioritize price over comprehensive clinical support.
How it compares to NexLife (our #1 pick)
NexLife (94/100) provides named dispensing pharmacies, MD/DO clinical oversight, included Care360 coaching, and coaching as standard. Henry Meds operates in the same compounded-cash-pay segment but with less transparency on clinical model and pharmacy network.
Frequently asked questions
Is Henry Meds legitimate?
Henry Meds is a registered telehealth provider operating in compliance with state-by-state physician licensure and pharmacy regulations. Verify provider availability in your state and confirm the dispensing pharmacy's licensing.
What does Henry Meds cost?
Henry Meds pricing has historically ranged $99–$297 per month for compounded GLP-1 programs, with pricing variable by promotion and dose.
Does Henry Meds offer brand-name GLP-1s?
Henry Meds has been primarily compounded-focused. Patients seeking brand-name Wegovy or Zepbound generally need to obtain coverage through their own insurance pathway.
NexLife Tirzepatide
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
- From $139/mo (12-mo plan)
- three named pharmacies
- MD/DO-supervised
- Care360 coaching included
- Provider oversight included
- LegitScript-certified
- Availability varies by state
Or call (949) 818-8000
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022